Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
24,328,806
-
Share change
-
-867,457
-
Total reported value
-
$2,807,626,031
-
Put/Call ratio
-
129%
-
Price per share
-
$115.41
-
Number of holders
-
258
-
Value change
-
-$83,703,544
-
Number of buys
-
90
-
Number of sells
-
117
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q4 2020
As of 31 Dec 2020,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
258 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,328,806 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, CANADA PENSION PLAN INVESTMENT BOARD, MORGAN STANLEY, Redmile Group, LLC, FEDERATED HERMES, INC., ETF MANAGERS GROUP, LLC, and M&G INVESTMENT MANAGEMENT LTD.
This page lists
258
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.